Abstract: Tumor necrosis factors and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human tumor necrosis factor receptor designated as “Ztnfr12.
Type:
Grant
Filed:
June 22, 2007
Date of Patent:
October 27, 2009
Assignee:
ZymoGenetics, Inc.
Inventors:
Jane A. Gross, Wenfeng Xu, Randal M. Henne, Francis J. Grant